P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 14.65 CNY -1.08% Market Closed
Market Cap: 5B CNY

Net Margin
Pulike Biological Engineering Inc

10.9%
Current
14%
Average
5.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
118.4m
/
Revenue
1.1B

Net Margin Across Competitors

Pulike Biological Engineering Inc
Glance View

Market Cap
5B CNY
Industry
Pharmaceuticals

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Intrinsic Value
17.89 CNY
Undervaluation 18%
Intrinsic Value
Price
P
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
118.4m
/
Revenue
1.1B
What is the Net Margin of Pulike Biological Engineering Inc?

Based on Pulike Biological Engineering Inc's most recent financial statements, the company has Net Margin of 10.9%.

Back to Top